Similar to Antcin A, compounds such as Dieckol (DK), MCC950 (a specific NLRP3 inhibitor), and VD also reduce pyroptosis by targeting NLRP3 inflammasome, thereby attenuating the accumulation of triglycerides and FFA, improving liver injury, and reducing NAFLD scores [99–101]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.